Veterinary Therapeutic Protein and Peptide Sequence Optimization

R&D Solutions

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Veterinary Therapeutic Protein and Peptide Sequence Optimization

Inquiry Now

Overview Molecular Modeling Point Mutation Service Workflow Why Choose Us?

In veterinary medicine, the optimization of therapeutic proteins and peptides is essential for creating more effective and tailored treatments for a range of animal health issues. Therapeutic protein and peptide sequence optimization is critical in bioinformatics and biotechnology, aiming to enhance the properties of these biomolecules for various veterinary applications. This process primarily involves sophisticated techniques such as molecular modeling and point mutation to refine the functionality and therapeutic efficacy of these molecules. BioVenic leverages advanced methodologies to significantly improve the pharmacological properties of therapeutic proteins and peptides for preclinical research, leading to more effective and specialized veterinary treatments.

Protein and Peptide Sequence Optimization Overview

Veterinary protein and peptide sequence optimization is critical for drug discovery and preclinical research, focusing on enhancing the properties of proteins and peptides for various applications. Compared with structure optimization, it has some obvious advantages, such as feasibility, high efficiency, direct impact on functionality, and scalability. Structure optimization is more dependent on the availability of high-resolution structure data, which is not always available for all proteins of interest. Meanwhile, manipulating protein structures can sometimes lead to unforeseen changes in protein dynamics and function, as some changes can have large ripple effects on a protein's overall structure. Thus, sequence optimization is vital for discovering and modifying therapeutic proteins and peptides for animal use. BioVenic also supports this technology for various animals, including companion pets, livestock, poultry, and fish industry, etc.

Protein and Peptide Molecular Modeling

Molecular modeling serves as a foundational tool, providing detailed insights into the structural configuration of proteins and peptides, which is crucial for identifying potential enhancements in their therapeutic actions. This computational technique involves simulating and analyzing the molecular and atomic interactions that govern the structure and function of biological molecules. In the context of veterinary medicine, molecular modeling is utilized to enhance the therapeutic efficacy and specificity of proteins and peptides designed to treat a variety of animal diseases. BioVenic offers comprehensive services in molecular modeling, providing tailored solutions that enhance protein and peptide lead optimization for veterinary applications, ensuring both efficacy and safety in therapeutic developments.

Fig.1 Protein molecular modeling workflow. (Saidulu, et al., 2018) Fig.1 The workflow of protein molecular modeling. ^{1, 2}

Molecular Modeling	Description	Services
Proteins	Fold assignment, which identifies the similarity between the target and at least one known template structure. Alignment of the target sequence and the template(s). Building a model based on the alignment with the chosen template(s). Predicting model errors. Modeling of protein structures involves predicting the three-dimensional arrangement of atoms within a protein molecule. It helps in understanding protein functions, interactions, and stability under various conditions.	Structure prediction. Docking simulation. Dynamic simulations. Functional annotation.
Peptides	Peptide modeling focuses on small chains of amino acids and involves the study of their configurations, interactions with other molecules, and potential for therapeutic applications. Peptides generally have simpler structures than proteins.	Conformation analysis. Binding affinity studies. Stability assessments.

Protein and Peptide Point Mutation

Meanwhile, point mutation techniques allow for precise alterations in the amino acid sequence, facilitating targeted improvements such as increased receptor affinity, enhanced stability, and reduced immunogenicity. Point mutation is a powerful tool in the biophysical sequence optimization of proteins and peptides, particularly in the development of veterinary therapeutics. This technique involves the deliberate alteration of specific amino acids within a protein or peptide sequence to improve its biological properties and therapeutic potential. BioVenic specializes in applying point mutation techniques for protein and peptide optimization, offering advanced point mutation methods and iterative testing services to enhance the efficacy and safety of veterinary therapeutics.

Fig.2 The point mutation scheme of proteins. (By Jonsta247, 2022) Fig.2 Point mutation scheme for the proteins.³

Point Mutation	Description	Services
Proteins	Point mutations in proteins involve changes to a single amino acid in the sequence, which can significantly affect the protein's structure, stability, function, and interactions.	Mutation impact analysis Protein re-engineering Functional testing. Stability testing.
Peptides	Point mutations in peptides refer to altering a single amino acid in a peptide chain. These changes can modify the peptide's activity, stability, and binding properties, often for therapeutic uses.	Peptide optimization. Activity assessment. Stability and solubility tests.

Service Workflow

Our veterinary therapeutic protein and peptide optimization service begins with a comprehensive consultation, where we delve into your specific requirements to craft a project plan. Once the details are established, we secure the collaboration with a contract, ensuring transparency and mutual protection. We then rigorously conduct experiments following strict protocols and deliver a detailed analysis report. To further support our clients, we provide extensive post-project assistance and professional services, ensuring seamless implementation and practical application of the findings.

Fig.3 Service workflow for sequence optimization in veterinary therapeutic proteins and peptides. (BioVenic Original) Fig.3 The veterinary therapeutic protein and peptide sequence optimization service workflow. (BioVenic Original)

Why Choose Us?

Advanced Bioinformatics Tools

BioVenic offers state-of-the-art tools designed for molecular modeling and point mutation analysis of therapeutic proteins and peptides in veterinary medicine.

Specialized in Sequence Optimization

Our team possesses deep expertise in optimizing protein and peptide sequences for veterinary applications, tailoring our approach to meet diverse objectives and requirements.

Innovative Analysis Methods

We utilize a variety of advanced analytical methods and software to interpret the outcomes of our therapeutic protein and peptide lead optimization processes.

Comprehensive After-sales Services

We provide detailed, extensive after-sales service to ensure that our clients fully comprehend and can effectively utilize their data, maximizing its impact and value.

Protein and peptide sequence optimization is a complex field that demands specific expertise to select the most suitable methods for each project's unique goals. BioVenic provides a broad array of proprietary protein and peptide sequence optimization technologies, enhanced with the latest in bioinformatics and medicinal chemistry. With over a decade of experience in managing R&D projects, we are equipped to provide diverse modified proteins and peptides that meet your specific sequence optimization needs. Whether you have precise goals or are seeking professional advice, we encourage you to contact us today to discover how we can help you achieve the best outcomes.

References

Mattapally, Saidulu, et al. "Computational modeling suggests impaired interactions between NKX2. 5 and GATA4 in individuals carrying a novel pathogenic D16N NKX2. 5 mutation." Oncotarget 9.17 (2018): 13713.
Image retrieved from Figure 1 "Scheme1: Flowchart of molecular modeling pipeline". Mattapally, Saidulu, et al., 2018, CC BY 3.0, the title was changed to "The workflow of protein molecular modeling ".
Image retrieved from Wikipedia: By Jonsta247, https://commons.wikimedia.org/wiki/File:Point_mutations-en.png, Jonsta247, 2022, used under CC BY-SA 4.0